CLINICAL_TRIALS
trial_result
· 2015-05-20
Clinical Trial Update: A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma [Phase 3]
Summary
Phase 3 trial comparing albuterol Spiromax to placebo in adolescents and adults with persistent asthma completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2015-05-20